               SEQUENCE LISTING

<110> LFB BIOTECHNOLOGIES

<120> Method for purifying transgenic Factor VII

<130> 32511EP LFB

<160> 41

<170> BiSSAP 1.0

<210> 1
<211> 22
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..22
<223> /mol_type="protein"
      /note="Antigen-Binding protein Framework 1 domain"
      /organism="artificial sequences"

<400> 1
Gly Gly Ser Val Gln Thr Gly Gly Ser Leu Arg Leu Ser Cys Glu Ile 
1               5                   10                   15    
Ser Gly Leu Thr Phe Asp 
            20        

<210> 2
<211> 22
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..22
<223> /mol_type="protein"
      /note="Antigen-Binding protein Framework 1 domain"
      /organism="artificial sequences"

<400> 2
Gly Gly Ser Val Gln Thr Gly Gly Ser Leu Arg Leu Ser Cys Ala Val 
1               5                   10                   15    
Ser Gly Phe Ser Phe Ser 
            20        

<210> 3
<211> 22
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..22
<223> /mol_type="protein"
      /note="Antigen-Binding protein Framework 1 domain"
      /organism="artificial sequences"

<400> 3
Gly Gly Ser Glu Gln Gly Gly Gly Ser Leu Arg Leu Ser Cys Ala Ile 
1               5                   10                   15    
Ser Gly Tyr Thr Tyr Gly 
            20        

<210> 4
<211> 22
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..22
<223> /mol_type="protein"
      /note="Antigen-Binding protein Framework 1 domain"
      /organism="artificial sequences"

<400> 4
Gly Gly Ser Val Gln Pro Gly Gly Ser Leu Thr Leu Ser Cys Thr Val 
1               5                   10                   15    
Ser Gly Ala Thr Tyr Ser 
            20        

<210> 5
<211> 22
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..22
<223> /mol_type="protein"
      /note="Antigen-Binding protein Framework 1 domain"
      /organism="artificial sequences"

<400> 5
Gly Gly Ser Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Thr Gly 
1               5                   10                   15    
Ser Gly Phe Pro Tyr Ser 
            20        

<210> 6
<211> 21
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..21
<223> /mol_type="protein"
      /note="Antigen-Binding protein Framework 1 domain"
      /organism="artificial sequences"

<400> 6
Gly Gly Ser Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Val Ala 
1               5                   10                   15    
Gly Phe Gly Thr Ser 
            20    

<210> 7
<211> 21
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..21
<223> /mol_type="protein"
      /note="Antigen-Binding protein Framework 1 domain"
      /organism="artificial sequences"

<400> 7
Gly Gly Ser Val Gln Ala Gly Gly Ser Leu Arg Leu Ser Cys Val Ser 
1               5                   10                   15    
Phe Ser Pro Ser Ser 
            20    

<210> 8
<211> 11
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..11
<223> /mol_type="protein"
      /note="Antigen-Binding protein Framework 4 domain"
      /organism="artificial sequences"

<400> 8
Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser 
1               5                   10    

<210> 9
<211> 11
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..11
<223> /mol_type="protein"
      /note="Antigen-Binding protein Framework 4 domain"
      /organism="artificial sequences"

<400> 9
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
1               5                   10    

<210> 10
<211> 11
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..11
<223> /mol_type="protein"
      /note="Antigen-Binding protein Framework 4 domain"
      /organism="artificial sequences"

<400> 10
Trp Gly Gln Gly Ala Gln Val Thr Val Ser Ser 
1               5                   10    

<210> 11
<211> 11
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..11
<223> /mol_type="protein"
      /note="Antigen-Binding protein Framework 4 domain"
      /organism="artificial sequences"

<400> 11
Trp Gly Gln Gly Thr Gln Val Thr Ala Ser Ser 
1               5                   10    

<210> 12
<211> 11
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..11
<223> /mol_type="protein"
      /note="Antigen-Binding protein Framework 4 domain"
      /organism="artificial sequences"

<400> 12
Arg Gly Gln Gly Thr Gln Val Thr Val Ser Leu 
1               5                   10    

<210> 13
<211> 14
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..14
<223> /mol_type="protein"
      /note="Antigen-Binding protein CDR3 domain"
      /organism="artificial sequences"

<220> 
<221> MOD_RES
<222> 12
<223> Xaa can be any naturally occuring amino acid

<400> 13
Ala Leu Gln Pro Gly Gly Tyr Cys Gly Tyr Gly Xaa Cys Leu 
1               5                   10                

<210> 14
<211> 12
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..12
<223> /mol_type="protein"
      /note="Antigen-Binding protein CDR3 domain"
      /organism="artificial sequences"

<400> 14
Val Ser Leu Met Asp Arg Ile Ser Gln His Gly Cys 
1               5                   10        

<210> 15
<211> 18
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..18
<223> /mol_type="protein"
      /note="Antigen-Binding protein CDR3 domain"
      /organism="artificial sequences"

<400> 15
Val Pro Ala His Leu Gly Pro Gly Ala Ile Leu Asp Leu Lys Lys Tyr 
1               5                   10                   15    
Lys Tyr 
        

<210> 16
<211> 15
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..15
<223> /mol_type="protein"
      /note="Antigen-Binding protein CDR3 domain"
      /organism="artificial sequences"

<400> 16
Phe Cys Tyr Ser Thr Ala Gly Asp Gly Gly Ser Gly Glu Met Tyr 
1               5                   10                   15

<210> 17
<211> 15
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..15
<223> /mol_type="protein"
      /note="Antigen-Binding protein CDR3 domain"
      /organism="artificial sequences"

<400> 17
Glu Leu Ser Gly Gly Ser Cys Glu Leu Pro Leu Leu Phe Asp Tyr 
1               5                   10                   15

<210> 18
<211> 17
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..17
<223> /mol_type="protein"
      /note="Antigen-Binding protein CDR3 domain"
      /organism="artificial sequences"

<400> 18
Asp Trp Lys Tyr Trp Thr Cys Gly Ala Gln Thr Gly Gly Tyr Phe Gly 
1               5                   10                   15    
Gln 
    

<210> 19
<211> 24
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..24
<223> /mol_type="protein"
      /note="Antigen-Binding protein CDR3 domain"
      /organism="artificial sequences"

<400> 19
Arg Leu Thr Glu Met Gly Ala Cys Asp Ala Arg Trp Ala Thr Leu Ala 
1               5                   10                   15    
Thr Arg Thr Phe Ala Tyr Asn Tyr 
            20                

<210> 20
<211> 16
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..16
<223> /mol_type="protein"
      /note="Antigen-Binding protein CDR3 domain"
      /organism="artificial sequences"

<400> 20
Gln Lys Lys Asp Arg Thr Arg Trp Ala Glu Pro Arg Glu Trp Asn Asn 
1               5                   10                   15    

<210> 21
<211> 21
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..21
<223> /mol_type="protein"
      /note="Antigen-Binding protein CDR3 domain"
      /organism="artificial sequences"

<400> 21
Gly Ser Arg Phe Ser Ser Pro Val Gly Ser Thr Ser Arg Leu Glu Ser 
1               5                   10                   15    
Ser Asp Tyr Asn Tyr 
            20    

<210> 22
<211> 16
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..16
<223> /mol_type="protein"
      /note="Antigen-Binding protein CDR3 domain"
      /organism="artificial sequences"

<220> 
<221> MOD_RES
<222> 11
<223> Xaa can be any naturally occuring amino acid

<400> 22
Ala Asp Pro Ser Ile Tyr Tyr Ser Ile Leu Xaa Ile Glu Tyr Lys Tyr 
1               5                   10                   15    

<210> 23
<211> 22
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..22
<223> /mol_type="protein"
      /note="Antigen-Binding protein CDR3 domain"
      /organism="artificial sequences"

<400> 23
Asp Ser Pro Cys Tyr Met Pro Thr Met Pro Ala Pro Pro Ile Arg Asp 
1               5                   10                   15    
Ser Phe Gly Trp Asp Asp 
            20        

<210> 24
<211> 15
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..15
<223> /mol_type="protein"
      /note="Antigen-Binding protein CDR3 domain"
      /organism="artificial sequences"

<400> 24
Thr Ser Ser Phe Tyr Trp Tyr Cys Thr Thr Ala Pro Tyr Asn Val 
1               5                   10                   15

<210> 25
<211> 16
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..16
<223> /mol_type="protein"
      /note="Antigen-Binding protein CDR3 domain"
      /organism="artificial sequences"

<400> 25
Thr Glu Ile Glu Trp Tyr Gly Cys Asn Leu Arg Thr Thr Phe Thr Arg 
1               5                   10                   15    

<210> 26
<211> 22
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..22
<223> /mol_type="protein"
      /note="Antigen-Binding protein CDR3 domain"
      /organism="artificial sequences"

<400> 26
Asn Gln Leu Ala Gly Gly Trp Tyr Leu Asp Pro Asn Tyr Trp Leu Ser 
1               5                   10                   15    
Val Gly Ala Tyr Ala Ile 
            20        

<210> 27
<211> 24
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..24
<223> /mol_type="protein"
      /note="Antigen-Binding protein CDR3 domain"
      /organism="artificial sequences"

<400> 27
Arg Leu Thr Glu Met Gly Ala Cys Asp Ala Arg Trp Ala Thr Leu Ala 
1               5                   10                   15    
Thr Arg Thr Phe Ala Tyr Asn Tyr 
            20                

<210> 28
<211> 24
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..24
<223> /mol_type="protein"
      /note="Antigen-Binding protein CDR3 domain"
      /organism="artificial sequences"

<400> 28
Asp Gly Trp Thr Arg Lys Glu Gly Gly Ile Gly Leu Pro Trp Ser Val 
1               5                   10                   15    
Gln Cys Glu Asp Gly Tyr Asn Tyr 
            20                

<210> 29
<211> 10
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..10
<223> /mol_type="protein"
      /note="Antigen-Binding protein CDR3 domain"
      /organism="artificial sequences"

<400> 29
Asp Ser Tyr Pro Cys His Leu Leu Asp Val 
1               5                   10

<210> 30
<211> 12
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..12
<223> /mol_type="protein"
      /note="Antigen-Binding protein CDR3 domain"
      /organism="artificial sequences"

<400> 30
Val Glu Tyr Pro Ile Ala Asp Met Cys Ser Arg Tyr 
1               5                   10        

<210> 31
<211> 27
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..27
<223> /mol_type="protein"
      /note="Antigen-Binding protein CH2 domain"
      /organism="artificial sequences"

<400> 31
Ala Pro Glu Leu Leu Gly Gly Pro Thr Val Phe Ile Phe Pro Pro Lys 
1               5                   10                   15    
Pro Lys Asp Val Leu Ser Ile Thr Leu Thr Pro 
            20                   25        

<210> 32
<211> 27
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..27
<223> /mol_type="protein"
      /note="Antigen-Binding protein CH2 domain"
      /organism="artificial sequences"

<400> 32
Ala Pro Glu Leu Pro Gly Gly Pro Ser Val Phe Val Phe Pro Thr Lys 
1               5                   10                   15    
Pro Lys Asp Val Leu Ser Ile Ser Gly Arg Pro 
            20                   25        

<210> 33
<211> 27
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..27
<223> /mol_type="protein"
      /note="Antigen-Binding protein CH2 domain"
      /organism="artificial sequences"

<400> 33
Ala Pro Glu Leu Pro Gly Gly Pro Ser Val Phe Val Phe Pro Pro Lys 
1               5                   10                   15    
Pro Lys Asp Val Leu Ser Ile Ser Gly Arg Pro 
            20                   25        

<210> 34
<211> 27
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..27
<223> /mol_type="protein"
      /note="Antigen-Binding protein CH2 domain"
      /organism="artificial sequences"

<400> 34
Ala Pro Glu Leu Leu Gly Gly Pro Ser Val Phe Ile Phe Pro Pro Lys 
1               5                   10                   15    
Pro Lys Asp Val Leu Ser Ile Ser Gly Arg Pro 
            20                   25        

<210> 35
<211> 12
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..12
<223> /mol_type="protein"
      /note="Antigen-Binding protein CH3 domain"
      /organism="artificial sequences"

<400> 35
Gly Gln Thr Arg Glu Pro Gln Val Tyr Thr Leu Ala 
1               5                   10        

<210> 36
<211> 18
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..18
<223> /mol_type="protein"
      /note="Antigen-Binding protein CH3 domain"
      /organism="artificial sequences"

<220> 
<221> MOD_RES
<222> 14
<223> Xaa can be any naturally occuring amino acid

<400> 36
Gly Gln Thr Arg Glu Pro Gln Val Tyr Thr Leu Ala Pro Xaa Arg Leu 
1               5                   10                   15    
Glu Leu 
        

<210> 37
<211> 18
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..18
<223> /mol_type="protein"
      /note="Antigen-Binding protein CH3 domain"
      /organism="artificial sequences"

<400> 37
Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Asp 
1               5                   10                   15    
Glu Leu 
        

<210> 38
<211> 18
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..18
<223> /mol_type="protein"
      /note="Antigen-Binding protein CH3 domain"
      /organism="artificial sequences"

<400> 38
Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu 
1               5                   10                   15    
Glu Met 
        

<210> 39
<211> 18
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..18
<223> /mol_type="protein"
      /note="Antigen-Binding protein CH3 domain"
      /organism="artificial sequences"

<400> 39
Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Gln Glu 
1               5                   10                   15    
Glu Met 
        

<210> 40
<211> 12
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..12
<223> /mol_type="protein"
      /note="Antigen-Binding protein Hinge domain"
      /organism="artificial sequences"

<400> 40
Gly Thr Asn Glu Val Cys Lys Cys Pro Lys Cys Pro 
1               5                   10        

<210> 41
<211> 35
<212> PRT
<213> artificial sequences

<220> 
<221> SOURCE
<222> 1..35
<223> /mol_type="protein"
      /note="Antigen-Binding protein Hinge domain"
      /organism="artificial sequences"

<400> 41
Glu Pro Lys Ile Pro Gln Pro Gln Pro Lys Pro Gln Pro Gln Pro Gln 
1               5                   10                   15    
Pro Gln Pro Lys Pro Gln Pro Lys Pro Glu Pro Glu Cys Thr Cys Pro 
            20                   25                  30        
Lys Cys Pro 
        35

